Could Machine Learning Predict Lupus Hospitalizations?
https://unsplash.com/photos/w7ZyuGYNpRQ

Could Machine Learning Predict Lupus Hospitalizations?

  Have you ever heard of machine learning? Machine learning is a form of artificial intelligence (AI) which teaches systems to learn, act, and improve an experience without explicit programming.…

Continue Reading Could Machine Learning Predict Lupus Hospitalizations?
Texas Woman Raises Lupus Awareness
Butterfly rash. Source: CNX OpenStax / CC BY (https://creativecommons.org/licenses/by/4.0)

Texas Woman Raises Lupus Awareness

As many people in the rare, chronic, or underserved disease community know, the journey to diagnosis can be a long and difficult one. For Texas resident Cheryl Yetz, the diagnostic…

Continue Reading Texas Woman Raises Lupus Awareness

ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity

  Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…

Continue Reading ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
Azathioprine: Specific Genotype Linked to Treatment Discontinuation Due to Toxicity
source: pixabay.com

Azathioprine: Specific Genotype Linked to Treatment Discontinuation Due to Toxicity

According to a story from Medpage Today, patients using the drug azathioprine who carried a certain genotype were three times more likely to need to either cease treatment or reduce…

Continue Reading Azathioprine: Specific Genotype Linked to Treatment Discontinuation Due to Toxicity
ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
https://pixabay.com/photos/student-typing-keyboard-text-woman-849822/

ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions

Since the company was founded, biotechnology company Kezar Life Sciences ("Kezar") has worked to develop therapies for patients with oncologic and autoimmune disorders. Recently, they highlighted a potential treatment, KZR-616,…

Continue Reading ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment
Alterfines / Pixabay

Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment

Dr. David Pisetsky, a translational researcher at the Medical Center of Duke University, recently described his team’s new approach to treating potential Lupus patients. The doctor told the Rheumatologist of…

Continue Reading Duke Researchers Help Lupus Patients By Improving Methods of Diagnosis and Treatment
Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years
source: pixabay.com

Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years

  Dr. Richard Furie at New York’s Feinstein Institutes recently interviewed with MedPage Today. Dr. Furie discussed the prognosis for lupus nephritis and belimumab (Benlysta), a recently-tested drug that appears…

Continue Reading Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)